Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
2,763
Views
7
CrossRef citations to date
0
Altmetric
Original Research

The immune microenvironment and relation to outcome in patients with advanced breast cancer treated with docetaxel with or without gemcitabine

Elisabeth S Stovgaarda Department of Pathology, Herlev and Gentofte, University of Copenhagen, Herlev, DenmarkORCID Iconhttps://orcid.org/0000-0002-5784-3610View further author information
ORCID Icon,
Karama Aslehb Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, CanadaView further author information
,
Nazia Riazb Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada;c Centre for Regenerative Medicine and Stem Cell Research, Aga Khan University, Karachi, PakistanView further author information
,
Samuel Leungb Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, CanadaView further author information
,
Dongxia Gaob Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, CanadaView further author information
,
Lise B Nielsend Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DenmarkView further author information
,
Anne-Vibeke Lænkholme Department of Surgical Pathology, Zealand University Hospital, Roskilde, DenmarkView further author information
,
Eva Balsleva Department of Pathology, Herlev and Gentofte, University of Copenhagen, Herlev, DenmarkView further author information
,
Maj-Britt Jensend Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen University Hospital, Copenhagen, DenmarkView further author information
,
Dorte Nielsenf Department of Oncology, Herlev and Gentofte, University of Copenhagen, Herlev, DenmarkView further author information
&
TO Nielsenb Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC, Canada;g Department of Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, BC, CanadaCorrespondence[email protected]
View further author information
 show all
Article: 1924492 | Received 25 Dec 2020, Accepted 23 Apr 2021, Published online: 11 May 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yongli Shi, Chunyan Li, Mingbo Yang, Xiaofei Pan & Jie Hu. (2022) Docetaxel-loaded redox-sensitive nanoparticles self-assembling from poly(caprolactone) conjugates with disulfide-linked poly(ethylene glycol). Journal of Biomaterials Science, Polymer Edition 33:17, pages 2185-2201.
Read now

Articles from other publishers (6)

Rongyang Li, Jianhao Qiu, Zhan Zhang, Chenghao Qu, Zhanpeng Tang, Wenhao Yu, Yu Tian & Hui Tian. (2023) Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis. Cancer Cell International 23:1.
Crossref
Song He, Zhonghao Ji, Qing Zhang, Xiwen Zhang, Jian Chen, Jinping Hu, Ruiqing Wang & Yu Ding. (2023) Investigation of LGALS2 expression in the TCGA database reveals its clinical relevance in breast cancer immunotherapy and drug resistance. Scientific Reports 13:1.
Crossref
Yalan Sun, Ying Wang, Fang Lu, Xianghong Zhao, Zhenlin Nie & Bangshun He. (2023) The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis. Clinical and Translational Oncology 25:6, pages 1830-1843.
Crossref
Aya Elmahs, Ghada Mohamed, Mostafa Salem, Dina Omar, Amany Mohamed Helal & Nahed Soliman. (2022) The Impact of Tumor Infiltrating Lymphocytes Densities and Ki67 Index on Residual Breast Cancer Burden following Neoadjuvant Chemotherapy. International Journal of Breast Cancer 2022, pages 1-10.
Crossref
Elahe Shenasa, Elisabeth Specht Stovgaard, Maj-Britt Jensen, Karama Asleh, Nazia Riaz, Dongxia Gao, Samuel Leung, Bent Ejlertsen, Anne-Vibeke Laenkholm & Torsten O. Nielsen. (2022) Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial. Cancers 14:15, pages 3808.
Crossref
RamaRao Malla, Vasudevaraju Padmaraju & Durga Bhavani Kundrapu. (2022) Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer. Life Sciences 301, pages 120572.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.